CompletedNCT00680888
Quetiapine treatment adherence after first psychosis in children and teens
About this title
Read the official source —Observational studyAges 7–17Schizophrenia
Understand this study
Who was this study for?
Listed age limits: 7 years to 17 years.
Study information
Study start dateAugust 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- Not clearly listed
- Age range
- From 7 Years to 17 Years
- Official registry ID
- NCT00680888
- Official title
Show the full official title
Adherence in Adolescents and Children Treated on Quetiapine
Get this study by email
Recruitment & locations
CompletedLocations not listed
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Who was this study for?
Listed age limits: 7 years to 17 years.
